Monday, July 4, 2022
Market-Reporter
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate
No Result
View All Result
Market-Reporter
No Result
View All Result
Home Stocks

Premarket: The stock market after-party is in Europe

MtR by MtR
June 8, 2021
in Stocks
0
Premarket: The stock market after-party is in Europe


In Europe, there’s no such hesitance.

Related articles

Here’s What I Learned Investing in Stocks for a Full Year

July 3, 2022

Nigerian Stock Market end first half of 2022 as one of the best in the world

July 3, 2022

What’s happening: The STOXX 600 index hit an all-time high on Monday and is pushing higher again on Tuesday. Strategists think that after a decade of skepticism, European shares could continue to be solid bets in the months to come.

“This is not 4 a.m. [at] the European party,” Jeffrey Sacks, head of investment strategy in Europe, the Middle East and Africa at Citi Private Bank, told me. “This is 9 p.m., so there’s a lot further to go.”

For the past 10 years, investors have been wary about pumping money into Europe, which has been beset by low economic growth, a weak euro, political risk and a struggling banking sector, Sacks said.

Now, he sees a different dynamic starting to play out, as EU member states start to spend money allocated through the bloc’s recovery fund and vaccination programs gather steam.

JPMorgan predicts that €390 billion ($475 billion) in grants and €360 billion ($438 billion) in loans will start to be rolled out this year and money could continue to feed through until 2026.

There are also structural reasons Europe appears poised for a breakout. The region has a high proportion of stocks like auto companies and banks that perform well when the economy is on the upswing. Many pay healthy dividends. The market relies less than the United States on shares of high-growth tech companies like Amazon and Apple (AAPL), which look less appealing when investors are concerned about interest rate hikes.

“We upgraded our tactical view on European equities to neutral in February, and are seeing more reasons to be optimistic about this asset class for the next six to 12 months,” BlackRock strategists told clients on Monday.

There are risks. Like the Federal Reserve, the European Central Bank — which meets Thursday — is vulnerable to a policy mistake that could hamper the economic rebound. Fears about Covid variants are also stymying the summer tourism season for the second year in a row.

But Sacks thinks that after many years of “disappointment,” this could be Europe’s time to shine, resulting in a US-style wave of mergers and acquisitions and even a retail trading frenzy.

Not just the European Union: The United Kingdom could also experience growth after investors stayed on the sidelines for years due to Brexit, while Asian shares stand to benefit as the trade environment improves.

Wall Street has long dominated markets. Over the past decade, the S&P 500 has rallied 236%, while Europe’s STOXX 600 rose roughly 86%, the FTSE 100 in London climbed about 27% and Hong Kong’s Hang Seng gained 56%. That means there’s lots of ground to make up.

Biogen’s Alzheimer’s drug is a Wall Street winner

Wall Street thinks Biogen’s new Alzheimer’s drug is poised to be a huge success.

On Monday, the US Food and Drug Administration approved the use of the experimental drug aducanumab for early-stage Alzheimer’s patients. It’s the first treatment for the disease to receive a green light from the regulator in nearly 20 years.
Shares of Biogen (BIIB), which developed the drug also known as Aduhelm with Japanese partner Eisai, surged 38% Monday.

The drug was developed for patients with mild cognitive impairment, not severe dementia. It’s intended to slow progression of Alzheimer’s disease, not just ease symptoms, and could be used to treat millions of people.

Massachusetts-based Biogen needs a new blockbuster medicine after generic versions of Tecfidera, its multiple sclerosis drug, arrived in the United States last year.

Biogen’s revenue dropped 25% last quarter compared to the previous year. Chief Financial Officer Michael McDonnell said this decline “was mostly driven by the continued impact of Tecfidera generics in the United States.”

Watch this space: Aduhelm, which received accelerated approval, will still be studied, and there is debate over its efficacy. An advisory committee concluded last year that there was not enough evidence to support the effectiveness of the treatment.

“FDA will continue to monitor Aduhelm as it reaches the market and ultimately the patient’s bedside,” Dr. Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research, said in Monday’s announcement.

There are also concerns around cost. Biogen announced on Monday that the wholesale cost of treatment with aducanumab, which requires an infusion once every four weeks, carries an annual cost around $56,000 for a high dose.

Jeff Bezos is going to space. Is that a risk to Amazon’s stock?

In the billionaire space race, Jeff Bezos is about to break new ground.

The latest: Bezos will fly to space on the first crewed flight of the New Shepard, the rocket ship made by his space company, Blue Origin. The flight is scheduled for July 20, just 15 days after he’s set to step down as CEO of Amazon (AMZN). He’ll be joined by his brother.

If all goes according to plan, Bezos — the world’s richest person, with a net worth of $187 billion — will be the first of the billionaire space tycoons to experience a ride aboard the rocket technology that he’s poured millions into developing, my CNN Business colleague Jackie Wattles reports.

Not even Elon Musk, whose SpaceX builds rockets powerful enough to enter orbit around Earth, has announced plans to travel to space aboard one of his company’s crew capsules. British billionaire Richard Branson has long said he would be among the first passengers aboard Virgin Galactic’s rocket-powered plane, but that flight is expected to take place later in 2021.

Investor insight: Bezos isn’t leaving Amazon entirely when his tenure as CEO ends, and will transition to the executive chairman role. Should investors be concerned, then, that the company’s founder and visionary is rocketing into space?

Up next

The US trade balance for April posts at 8:30 a.m. ET, followed by data on job openings at 10 a.m. ET.

Coming tomorrow: GameStop (GME) reports earnings as its stock continues to soar.



Source link

Related Posts

Here’s What I Learned Investing in Stocks for a Full Year

by MtR
July 3, 2022
0

If you've been paying even the slightest bit of attention to the stock market, you know that it's way down...

Nigerian Stock Market end first half of 2022 as one of the best in the world

by MtR
July 3, 2022
0

The Nigerian All Share Index closed the first half of 2022 with a gain of about 21.17% year to date...

Stock Picks to Buy, Recession Investing Advice From BofA

by MtR
July 3, 2022
0

Stocks endured a brutal first half of 2022 as investors felt a recession was getting more likely.  Jill Carey Hall...

Global factors, crude oil, macro data to drive stocks this week: Analysts

by MtR
July 3, 2022
0

Stock markets would be driven by domestic macroeconomic data, global trends, crude oil movement and FII...

Top Piotroski-Graham Long Term Value Stocks: July 2022 Semi-Annual Selections

by MtR
July 3, 2022
0

SCStock/iStock Editorial via Getty Images Top Piotroski-Graham Long Term Value Stocks: July 2022 Semi-Annual Selections These selections continue as ongoing...

Load More
  • Trending
  • Comments
  • Latest

Bank of England tells ministers to intervene on digital currency ‘programming’

June 21, 2021

Tips for checking smoke alarms during daylight saving time

March 12, 2022

GLOBAL MARKETS-U.S. stocks follow Europe up; Treasury yields rise, dollar firm

July 9, 2021
Fed tapering and emerging markets

Fed tapering and emerging markets

June 7, 2021
African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

African currencies week ahead: Zambia's kwacha seen on back foot, Kenyan shilling up – Business Recorder

0
Maxum Foods releases Global Dairy Commodity Update for June

Maxum Foods releases Global Dairy Commodity Update for June

0
Letter: Perpetual bonds can help states fight hunger

Letter: Perpetual bonds can help states fight hunger

0
United Kingdom ETFs Are Riding the Re-Opening Momentum

United Kingdom ETFs Are Riding the Re-Opening Momentum

0

Your queries: Mutual Funds | Children’s funds invest in a mix of equity and debt

July 3, 2022

5 assets investors are buying in the dip: From commodities to ETFs

July 3, 2022

Belagavi Postal Division Tops In Gold Bond Sale | Hubballi News

July 3, 2022

Record Breakers: Four key commodity predictions from Canberra’s pen-pushers

July 3, 2022

Recent News

Your queries: Mutual Funds | Children’s funds invest in a mix of equity and debt

July 3, 2022

5 assets investors are buying in the dip: From commodities to ETFs

July 3, 2022

Belagavi Postal Division Tops In Gold Bond Sale | Hubballi News

July 3, 2022

Categories

  • Asia
  • Bonds
  • Canada
  • Commodities
  • Cryptocurrencies
  • Currencies
  • Emerging Markets
  • ETFs
  • Europe & Middle East
  • IPOs
  • Latin America
  • Mutual Funds
  • Personal Finance
  • Real Estate
  • Retirement
  • Spending & Saving
  • Stocks
  • U.S. Markets
  • Privacy & Policy
  • About Us
  • Contact Us
  • Advertise with us

© 2021 Copyright Market-Reporter

No Result
View All Result
  • Home
  • Markets
    • U.S. Markets
    • Canada
    • Europe & Middle East
    • Emerging Markets
    • Asia
    • Latin America
  • Investing
    • Stocks
    • IPOs
    • Mutual Funds
    • ETFs
    • Bonds
    • Commodities
    • Currencies
    • Cryptocurrencies
  • Economy & Politics
    • Personal Finance
    • Spending & Saving
    • Retirement
    • Real Estate

© 2021 Copyright Market-Reporter